|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C07D 487/04 | (2006.01) |
| A61K 31/55 | (2006.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61P 43/00 | (2006.01) |
| (11) | Number of the document | 2722334 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13192666.9 |
| Date of filing the European patent application | 2010-08-06 | |
| (97) | Date of publication of the European application | 2014-04-23 |
| (45) | Date of publication and mention of the grant of the patent | 2016-01-13 |
| (46) | Date of publication of the claims translation | 2016-04-11 |
| (30) | Number | Date | Country code |
| 0919433 | 2009-11-05 | GB | |
| 201010509 | 2010-06-22 | GB |
| (72) |
Gosmini, Romain Luc Marie, FR
Mirguet, Olivier, FR
|
| (73) |
GlaxoSmithKline LLC,
Corporation Service Company 2711 Centerville Road Suite 400, Wilmington DE 19808,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Benzodiazepino bromo domeno inhibitoriai |
| Benzodiazepine bromodomain inhibitor |
| Payment date | Validity (years) | Amount | |
| 2020-07-14 | 11 | 289.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2021-08-06 |